|
Congressional:
Senate Parliamentarian rules on Finance, HELP Provisions
On Thursday, Senate Budget Committee Ranking Member Jeff Merkley (D-OR) reported that several provisions of the reconciliation bill impacting health care stakeholders were ruled out of compliance by the Senate Parliamentarian. Most notably, for Health, Education, Labor, and Pensions Committee provisions, the Senate parliamentarian, Elizabeth MacDonough, rejected the appropriation of cost-sharing reduction subsidies and the bill’s limitation to qualified health plans that do not cover elective abortion. A full list of provisions ruled out of compliance under the Health, Education, Labor, and Pensions (HELP) Committee’s jurisdiction can be found here.
According to Senate Budget Democrats, the Senate parliamentarian also ruled that several Senate Finance Committee healthcare provisions would be subject to a 60-vote Byrd Rule point of order if not removed or modified. The provisions included:
- Prohibiting federal financial participation under Medicaid and CHIP for individuals without verified citizenship, nationality, or satisfactory immigration status.
- Denying federal funding to states for Medicaid coverage for certain immigrants who are not citizens.
- Expansion of FMAP for certain states providing payments for health care furnished to coverage to people who are undocumented using the state’s own funds.
- Requiring Medicaid managed care contracts with pharmacy benefit managers to adopt state reimbursement methodologies for pharmacy reimbursement.
- Prohibiting Federal Medicaid and Children’s Health Insurance Program (CHIP) Funding for Gender Affirming Care.
- Prohibiting non-expansion states from increasing the rate of current provider taxes or increasing the base of the tax to a class or items of services that the tax did not previously apply.
- Revoking eligibility to enroll in the Medicare program for refugees, asylum seekers, and people with temporary protected status who are not citizens.
- Limiting non-citizens from qualifying for premium tax credits or cost-sharing reductions beginning in 2027.
- Disallowing premium tax credit on the Affordable Care Act Marketplaces during periods of Medicaid ineligibility due to immigrant status.
Provisions ruled out of compliance under the Finance Committee’s jurisdiction can be found here. Senate Republicans on Thursday said they have revisions to some of the key Medicaid policies that could remedy their violation of the Byrd rule.
Senate Finance Committee Circulates Memo on Rural Health Transformation Program
On Wednesday, the Senate Finance Committee circulated a memo outlining plans to add a $15 billion stabilization fund for rural hospitals to the reconciliation bill. The proposal comes in response to several Republicans representing states that have expanded Medicaid criticizing proposed limits to state use of healthcare provider taxes over potential harm to rural hospitals in their states. The policy would create a $3 billion annual rural hospital fund for fiscal years 2027 to 2031. All states would be eligible to seek funding for specific projects from that pool by applying for a waiver through the Centers for Medicare and Medicaid Services. Senator Susan Collins (R-ME) stated that the proposal was not enough money, noting, "Obviously, any money is helpful, but no, it is not adequate. But I do not know for certain that that is where the Finance Committee has landed.” Read the memo here.
House Appropriations Committee Advances Fiscal Year 2026 FDA Funding Bill
On Monday, Republicans on the House Appropriations Committee advanced legislation that funds the Food and Drug Administration (FDA) for fiscal year 2026 on a party-line 35-27 vote. The bill’s funding levels remain unchanged from the President’s proposed budget request last month. The legislation would provide the FDA with $3.2 billion in taxpayer funds, a $300 million reduction from fiscal year 2025, and $3.6 billion in user fees paid by drug and device manufacturers, for a total of $6.8 billion in funding. The bill now moves to the House floor, but the timing for consideration is unclear. Read the press release and bill here.
House Education & Workforce Committee Advances Association Health Plans Bill
On Wednesday, the House Committee on Education & the Workforce held a markup, voting along party lines to approve the Association Health Plans Act (H.R. 2528), a bill that would allow small businesses and self-employed individuals to join together and purchase health coverage through association health plans. The legislation was introduced by Committee Chair Tim Walberg (R-MI) earlier this year.
House Passes Bills on Human Cell and Tissue Products, Organ Donor Discrimination
On Monday, the House passed two bills under suspension of the rules. The first bill, the Shandra Eisenga Human Cell and Tissue Product Safety Act (H.R.1082), sponsored by Rep. John Moolenaar, aims to strengthen enforcement of FDA safeguards for human cell and tissue products by imposing penalties of up to $20,000 per violation and per day, with a $10 million cap per proceeding. It would also require the FDA to publish educational materials, hold a public workshop on best practices, and submit a regulatory report to Congress by September 30, 2026. The second bill, the Charlotte Woodward Organ Transplant Discrimination Prevention Act (H.R.1520), sponsored by Rep. Kat Cammack, would prohibit discrimination against individuals with disabilities in organ transplant decisions. Specifically, the legislation would bar the Organ Procurement and Transplantation Network and health care providers from denying transplants based solely on disability, except when medically relevant.
House Energy & Commerce Health Subcommittee Holds Hearing on Proposed FY2026 HHS Budget
On Tuesday, the House Energy and Commerce Committee held a hearing with Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. to examine the President’s proposed fiscal year 2026 HHS budget. During the hearing, Kennedy faced bipartisan questioning on several topics, including vaccine policy, Medicaid, rural hospital funding, and scientific integrity. Republicans emphasized the need to reduce federal healthcare spending, restructure HHS for efficiency, and prioritize innovation, chronic disease prevention, and AI integration. Democrats largely criticized the proposed budget, warning it would cut critical programs, including those for maternal health, substance use, and chronic disease prevention, and were critical of the administration for undermining science, public health infrastructure, and healthcare access. Secretary Robert F. Kennedy, Jr. defended the administration’s approach as a realignment toward outcome-based care, reduced bureaucracy, and cost-saving reforms. Read Mehlman’s hearing summary here.
House Ways and Means Health Subcommittee Holds Hearing on Digital Health
On Wednesday, the House Ways & Means Health Subcommittee held a hearing on digital health data. During the hearing, Republicans primarily focused on the potential of wearable technology, remote patient monitoring (RPM), and artificial intelligence to reduce healthcare costs, improve outcomes, and empower personal responsibility, especially in rural areas. Democrats emphasized that while digital tools show promise, access to them depends on preserving healthcare coverage and affordability, warning that proposed federal cuts under the One Big Beautiful Bill (H.R. 1) would leave millions uninsured and undermine innovation. Witnesses from across sectors highlighted the real-world impact of digital health tools in improving prevention, chronic care, and workforce wellness, while calling for policy reforms on reimbursement, privacy protections, and equitable access. Read Mehlman’s hearing summary here.
Senate HELP Committee Holds Nomination Hearing for Susan Monarez to Lead CDC
On Wednesday, the Senate Health, Education, Labor and Pensions (HELP) Committee held a hearing to examine the nomination of Susan Monarez to lead the Centers for Disease Control and Prevention (CDC). Monarez was previously deputy director of the Advanced Research Projects Agency for Health under the Department of Health and Human Services (HHS). During the hearing, Monarez focused her testimony on the administration's goal of returning the CDC's mission to "preventing, detecting, and responding to infectious diseases and emerging threats." Monarez largely declined to distance herself from the decisions of HHS Secretary Robert F. Kennedy Jr., including firing members from the CDC's Advisory Committee on Immunization Practices (ACIP), stating that ACIP members should "use science and evidence to drive that decision-making." She added that "We absolutely need highly trained scientists and medical professionals to be able to participate in the ACIP meeting." Throughout the hearing, Monarez declined to directly answer several questions, including whether the U.S. should have ended its financial support of a global vaccine distribution organization, whether HHS will add more seats to the ACIP committee, the number one cause of death among children, or whether she agreed with Kennedy's comments that it is difficult for measles to kill a healthy person. HELP Chair Bill Cassidy (R-LA) has not yet announced when the HELP committee will vote to advance Monarez’s nomination to the Senate floor. Read Monarez’s testimony here.
Notable Bills Introduced:
Representatives Matsui and Crenshaw Introduce Bipartisan Bill to Prevent Drug Shortages by Addressing Vulnerabilities in the Pharmaceutical Supply Chain
On Thursday, Representatives Doris Matsui (D-CA) and Congressman Dan Crenshaw (R-TX) introduced the Mapping America’s Pharmaceutical Supply (MAPS) Act, bipartisan legislation to strengthen the federal government’s ability to prepare for and mitigate future drug shortages by identifying vulnerabilities in the pharmaceutical supply chain. The bill would require the Department of Health and Human Services (HHS) to update its Essential Medicines List and create a map of the pharmaceutical supply chain. The map would include the country of origin, quantity manufactured, and other key information about critical drug products to identify supply chain weaknesses that could lead to shortages or other challenges in a future public health emergency. Read the press release here and the bill here.
Senators Hawley, Hassan, Kelly Reintroduce Bipartisan Bill to Strengthen Rural Hospital Cybersecurity
On Wednesday, Senators Josh Hawley (R-MO), Maggie Hassan (D-NH), and Mark Kelly (D-AZ) reintroduced the Rural Hospital Cybersecurity Enhancement Act, which directs the Department of Health and Human Services (HHS) to develop a comprehensive strategy to address the growing need for skilled cybersecurity professionals in rural hospitals. The strategy aims to improve cybersecurity preparedness and create a robust workforce to protect vulnerable critical infrastructure, specifically rural hospitals, from cyber threats. The legislation unanimously passed out of a Senate committee last Congress. Read the press release here and the bill here.
Representatives Harshbarger, Sherrill Reintroduce Bipartisan Legislation to Digitize Prescription Information, Improve Patient Safety
On Wednesday, Representatives Diana Harshbarger (R-TN) and Mikie Sherrill (D-NJ) reintroduced the bipartisan Prescription Information Modernization Act. The legislation would allow the Food and Drug Administration (FDA) to move forward with a proposed rule allowing drug manufacturers to transmit prescribing information electronically to doctors and pharmacists, as opposed to a printed copy, as currently required. Read the press release here and the bill here.
Representative Grothman Reintroduces Bipartisan Bill to Lower Costs for Cancer Patients
On Tuesday, Representatives Glenn Grothman (R-WI), Suzanne Bonamici (D-OR), Gus Bilirakis (R-FL), Joe Morelle (D-NY), Brian Fitzpatrick (R-PA), and Doris Matsui (D-CA) reintroduced the bipartisan Cancer Drug Parity Act, which will lower costs for cancer patients prescribed oral medications. The bill requires health insurers to cover oral cancer treatments on the same level as traditional intravenous (IV) therapies. Read the press release here and the bill here.
Executive Branch:
CMS Finalizes 2025 Marketplace Integrity and Affordability Final Rule
Late last week, on Friday, the Centers for Medicare and Medicaid Services (CMS) released the 2025 Marketplace Integrity and Affordability final rule aimed at curbing improper enrollments and reducing premiums on the ACA Marketplace. For plan year 2026, the rule repeals the monthly special enrollment period (SEP) for individuals with projected household incomes at or below 150% of the federal poverty level, citing broker abuse, and increases income and eligibility verification for premium tax credits, and requires individuals who are automatically re-enrolled in a qualified health plan with a $0 premium and do not confirm their eligibility to pay a $5 monthly premium. It also standardizes the open enrollment period to end on December 31, starting in 2027. The rule also removes Deferred Action for Childhood Arrivals (DACA) recipients from the definition of “lawfully present” for eligibility and enrollment in Exchanges and Basic Health Program (BHP) coverage in states that elect to operate a BHP and prohibits the inclusion of sex-trait modification procedures in an essential health benefits package. CMS Administrator Dr. Mehmet Oz stated that these changes will “restore integrity to ACA Exchanges by cracking down on fraud, protecting American taxpayer dollars, and ensuring coverage is there for those who truly need it." Read the fact sheet here and the final rule here.
CDC’s Advisory Committee on Immunization Practices Recommends Removal of Thimerosal from Vaccines
The Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) held a meeting on Wednesday and Thursday to discuss and vote on vaccine recommendations. The panel is comprised of entirely new members appointed by Health and Human Services (HHS) Secretary Robert F. Kennedy Jr., after Kennedy fired all 17 members of the panel last month. The panel voted on Thursday that the public should not receive vaccines containing thimerosal, a mercury-containing preservative. Thimerosal is used in multidose flu vaccine vials to prevent contamination when the second dose is pulled, according to the Food and Drug Administration (FDA). The CDC has previously stated that there is no evidence to suggest that the amount of thimerosal included in some flu vaccines is harmful. Read the CDC’s press release here.
HRSA Announces Action to Lower Out-of-Pocket Costs for Life-Saving Medications at Health Centers Nationwide
On Tuesday, the Health Resources and Services Administration (HRSA) announced new steps to lower out-of-pocket costs for life-saving medications. In alignment with President Trump’s Executive Order Lowering Drug Prices by Putting Americans First, HRSA has issued updated award terms requiring HRSA-funded health centers to provide insulin and injectable epinephrine to low-income patients at or below the price paid by the center through the 340B Drug Pricing Program. Read the press release here.
HHS Secretary Kennedy, CMS Administrator Oz Tout Industry Pledge to Improve Prior Authorization Process
On Monday, Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr. and Centers for Medicare & Medicaid Services (CMS) Administrator Dr. Mehmet Oz met with industry leaders to discuss efforts to streamline and improve the prior authorization process across Medicare Advantage, Medicaid Managed Care, the Health Insurance Marketplace, and commercial plans. During a roundtable hosted by HHS, major health insurers pledged to implement six key reforms aimed at reducing administrative burden, speeding up care decisions, and increasing transparency for both patients and providers. These commitments include standardizing electronic prior authorization submissions using FHIR-based APIs, reducing the number of services requiring prior authorization by 2026, and honoring existing approvals during insurance transitions. Insurers also pledged to improve communication around authorization decisions and appeals, expand real-time decision-making with most requests approved instantly by 2027, and ensure medical professionals review all clinical denials. Read the press release here.
Legal & Other:
Supreme Court Preserves ACA Coverage of Preventive Health Care
On Friday, the Supreme Court ruled to preserve the provision of the Affordable Care Act (ACA) that requires insurance companies to cover preventive health services at no cost to patients. In a 6-3 vote, with Justice Brett Kavanaugh writing the majority opinion, the Supreme Court rejected the argument that the U.S. Preventive Services Task Force wielded so much power that they amount to “principal officers” under the Constitution’s appointments clause and must be appointed by the president and confirmed by the Senate. The majority opinion wrote that the “Task Force members issue preventive-services recommendations of critical importance to patients, doctors, insurers, employers, healthcare organizations, and the American people more broadly. In doing so, however, the Task Force members remain subject to the Secretary of HHS’s supervision and direction, and the Secretary remains subject to the President’s supervision and direction.” Read the opinion here.
Supreme Court Allows States to Exclude Medicaid Funding for Planned Parenthood
On Thursday, the Supreme Court ruled against Planned Parenthood, in a 6-3 decision divided along ideological lines, that Medicaid patients do not have a right to sue to obtain non-abortion health care from the organization’s medical providers. The decision rejected a challenge to South Carolina’s expulsion of Planned Parenthood from its Medicaid program. It will likely allow other conservative states to similarly expel reproductive and sexual health clinics from receiving Medicaid payments for any of their other non-abortion-related care. The majority ruled that while federal law guarantees Medicaid beneficiaries the right to see any “qualified and willing” provider, the statute does not grant patients legal standing to sue if a state denies access to certain providers. Read the opinion here.
|